Congressional Report Explains Implications—And Limitations—Of Trump's Marijuana Rescheduling Move For Users And Industry

Congressional Report Explains Implications—And Limitations—Of Trump's Marijuana Rescheduling Move For Users And Industry

Congressional researchers are laying out the scope and limitations of the Trump administration’s marijuana rescheduling action—explaining that while certified patients who possess medical cannabis from state-licensed dispensaries now have certain protections, the industry as a whole isn’t “immediately” considered to be in “full compliance” with federal law, particularly as it concerns recreational products. In a report published by the Congressi…

Trump's Marijuana Rescheduling: Big Headlines, Narrower Reality

Trump's marijuana executive order moved medical cannabis to Schedule III, but recreational programs, banking, and criminal records remain.

'Not Immediately Compliant': What the CRS Says America's Rescheduling Order Actually Delivers

Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.  While Acting Attorney General Todd Blanche’s order moving state-licensed medical cannabis to Schedule III successfully pushed the long-awaited reclassification over the line, it raised more questions than it answered in terms of legal process.  Now, the non-partisan …

Report: Congressional Research Service Says DOJ Medical Marijuana Order Could Ease 280E, Research Barriers

The Marijuana Herald - Marijuana news and information A new report from the Congressional Research Service says the Department of Justice’s recent order rescheduling certain medical marijuana products to Schedule III could have major implications for state-licensed medical marijuana businesses, patients, researchers and federal tax policy. The report analyzes DOJ’s April 23 final order, which moved marijuana and marijuana-derived products to Sch…

Congressional Report Explains Implications—And Limitations—Of Trump’s Marijuana Rescheduling Move For Users And Industry

Congressional researchers are laying out the scope and limitations of the Trump administration's marijuana rescheduling action-explaining that while certified patients who possess medical cannabis from state-licensed dispensaries now have certain protections, the industry as a whole isn't "immediately" considered to be in "full compliance" with federal law, particularly as it concerns recreational products. In a report published by the Congressi…